These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25877959)

  • 1. A combination of spin diffusion methods for the determination of protein-ligand complex structural ensembles.
    Pilger J; Mazur A; Monecke P; Schreuder H; Elshorst B; Bartoschek S; Langer T; Schiffer A; Krimm I; Wegstroth M; Lee D; Hessler G; Wendt KU; Becker S; Griesinger C
    Angew Chem Int Ed Engl; 2015 May; 54(22):6511-5. PubMed ID: 25877959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accounting for conformational variability in protein-ligand docking with NMR-guided rescoring.
    Skjærven L; Codutti L; Angelini A; Grimaldi M; Latek D; Monecke P; Dreyer MK; Carlomagno T
    J Am Chem Soc; 2013 Apr; 135(15):5819-27. PubMed ID: 23565800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-the-Fly Integration of Data from a Spin-Diffusion-Based NMR Experiment into Protein-Ligand Docking.
    Onila I; ten Brink T; Fredriksson K; Codutti L; Mazur A; Griesinger C; Carlomagno T; Exner TE
    J Chem Inf Model; 2015 Sep; 55(9):1962-72. PubMed ID: 26226383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography.
    Amano Y; Yamaguchi T; Tanabe E
    Bioorg Med Chem; 2014 Apr; 22(8):2427-34. PubMed ID: 24656800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of docking in large, flexible and promiscuous binding sites.
    Kotev M; Soliva R; Orozco M
    Bioorg Med Chem; 2016 Oct; 24(20):4961-4969. PubMed ID: 27545443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.
    Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE
    Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.
    Chen H; Zhang Y; Li L; Han JG
    J Phys Chem B; 2012 Aug; 116(34):10219-33. PubMed ID: 22857012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of site-directed spin labeling for characterizing protein-ligand complexes using simulated restraints.
    Constantine KL
    Biophys J; 2001 Sep; 81(3):1275-84. PubMed ID: 11509344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in glycogen phosphorylase inhibitor design.
    Oikonomakos NG; Somsák L
    Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallography-independent determination of ligand binding modes.
    Orts J; Tuma J; Reese M; Grimm SK; Monecke P; Bartoschek S; Schiffer A; Wendt KU; Griesinger C; Carlomagno T
    Angew Chem Int Ed Engl; 2008; 47(40):7736-40. PubMed ID: 18767090
    [No Abstract]   [Full Text] [Related]  

  • 12. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
    Chen H; Zhang Y; Ye C; Feng TT; Han JG
    J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
    Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
    Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
    Brylinski M
    J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From structure--based to knowledge--based drug design through x-ray protein crystallography: sketching glycogen phosphorylase binding sites.
    Chrysina ED; Chajistamatiou A; Chegkazi M
    Curr Med Chem; 2011; 18(17):2620-9. PubMed ID: 21568887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors.
    Benltifa M; Hayes JM; Vidal S; Gueyrard D; Goekjian PG; Praly JP; Kizilis G; Tiraidis C; Alexacou KM; Chrysina ED; Zographos SE; Leonidas DD; Archontis G; Oikonomakos NG
    Bioorg Med Chem; 2009 Oct; 17(20):7368-80. PubMed ID: 19781947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
    Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
    J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Improved Comparative Docking Approach for Developing Specific Glycogen Phosphorylase Inhibitors Using Pentacyclic Triterpenes.
    Konkimalla VB
    Curr Top Med Chem; 2017; 17(14):1640-1645. PubMed ID: 27823565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An NMR-based scoring function improves the accuracy of binding pose predictions by docking by two orders of magnitude.
    Orts J; Bartoschek S; Griesinger C; Monecke P; Carlomagno T
    J Biomol NMR; 2012 Jan; 52(1):23-30. PubMed ID: 22167466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.